Loading clinical trials...
Loading clinical trials...
Romosozumab Versus Denosumab in Patients With Glucocorticoid-induced Osteoporosis: a 2-year Extension Study of a Randomized Controlled Trial
Conditions
Interventions
Romosozumab
Denosumab
Locations
1
China
Department of Medicine, Tuen Mun Hospital
Hong Kong, China
Start Date
August 20, 2024
Primary Completion Date
December 1, 2025
Completion Date
March 1, 2026
Last Updated
November 22, 2024
NCT06558188
NCT06449742
NCT07474571
NCT06541548
NCT07254429
NCT07412782
Lead Sponsor
Tuen Mun Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions